Evidence map›Paper›PMID 28597919›Full record

Trial reportJournal of clinical pharmacology2017

An Open-Label Dose-Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients.

Elaine Rutherford, Graham Stewart, J Graeme Houston, Alan G Jardine, Patrick B Mark, Allan D Struthers

Open access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Elaine RutherfordInstitute of Cardiovascular & Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.ORCID 0000-0001-9818-8758
Graham StewartRenal Unit, Ninewells Hospital & Medical School, Dundee, UK.
J Graeme HoustonDivision of Molecular & Clinical Medicine, School of Medicine, Ninewells Hospital and Medical School, Dundee, UK.
Alan G JardineInstitute of Cardiovascular & Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Patrick B MarkInstitute of Cardiovascular & Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Allan D StruthersDivision of Molecular & Clinical Medicine, School of Medicine, Ninewells Hospital and Medical School, Dundee, UK.
British Heart Foundation · GBNinewells Hospital · GB

Funding

British Heart Foundation PG/12/72/29743
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AllopurinolDose-Response Relationship, DrugDouble-Blind MethodEnzyme InhibitorsFemaleGout SuppressantsHumansKidney Failure, ChronicMaleMiddle AgedRenal DialysisTreatment OutcomeUric AcidAllopurinolEnzyme InhibitorsGout SuppressantsUric Acidallopurinolclinical trialdosinghemodialysisurate

Identifiers

PMID28597919
PMCPMC5655768
OpenAlexW2617156879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.